Co-Diagnostics and CoSara to Launch IVD Products to India Market
Retrieved on:
Thursday, January 2, 2020
The India Diagnostic Expo provides Indias only focused diagnostics products and consumables exhibition for the diagnostic services market, which is expected to continue growing at 27.5% for the next 5 years.
Key Points:
- The India Diagnostic Expo provides Indias only focused diagnostics products and consumables exhibition for the diagnostic services market, which is expected to continue growing at 27.5% for the next 5 years.
- Attendance at the expo follows the December 2019 announcement that CoSara tests for tuberculosis, malaria, hepatitis B, hepatitis C and human papillomavirus (HPV) received IVD approval by the Central Drug Standard Control Organization (CDSCO).
- The Company and CoSara invite attendees to visit them at Booth #C-108 daily from 10 AM to 6 PM at the Hitex Exhibition Center, Venue Hall 3.
- Dwight Egan, CEO of Co-Diagnostics, commented We are pleased to officially launch these newly-approved diagnostics tests into India.